Table 3 Stratified analysis of ESRD incidence according to baseline eGFR and TUG categories

15–29

−10

1713

659

104.26

1 (ref.)

1 (ref.)

1 (ref.)

1 (ref.)

1 (ref.)

10–14.9

627

223

97.53

0.94 (0.81–1.09)

0.98 (0.84–1.14)

0.96 (0.82–1.11)

0.99 (0.85–1.15)

0.96 (0.82–1.12)

151–9.9

112

52

124.65

1.20 (0.90–1.59)

1.32 (0.99–1.75)

1.26 (0.95–1.68)

1.19 (0.89–1.58)

1.12 (0.86–1.47)

20–

33

11

105.54

1.02 (0.56–1.86)

1.32 (0.73–2.40)

1.12 (0.62–2.05)

1.41 (0.78–2.58)

0.76 (0.37–1.58)

30–59

−10

114,180

1120

1.89

1 (ref.)

1 (ref.)

1 (ref.)

1 (ref.)

1 (ref.)

10–14.9

37,043

413

2.04

1.05 (0.93–1.17)

1.12 (1.00–1.25)

1.02 (0.91–1.14)

1.04 (0.93–1.16)

1.03 (0.92–1.16)

15–19.9

5510

71

2.25

1.13 (0.89–1.44)

1.22 (0.96–1.56)

1.03 (0.81–1.32)

0.97 (0.76–1.23)

0.93 (0.72–1.21)

20–

1053

16

2.72

1.37 (0.84–2.25)

1.55 (0.95–2.55)

1.08 (0.66–1.77)

1.00 (0.61–1.64)

0.94 (0.56–1.58)

60–89

−10

798,406

802

0.20

1 (ref.)

1 (ref.)

1 (ref.)

1 (ref.)

1 (ref.)

10–14.9

219,894

284

0.25

1.19 (1.04–1.36)

1.21 (1.05–1.38)

1.16 (1.01–1.33)

1.13 (0.99–1.30)

1.11 (0.97–1.28)

15–9.9

29,361

48

0.30

1.38 (1.03–1.85)

1.40 (1.04–1.87)

1.31 (0.97–1.75)

1.24 (0.93–1.66)

1.22 (0.90–1.64)

20–

4851

15

0.57

2.67 (1.60–4.46)

2.71 (1.63–4.53)

2.41 (1.44–4.01)

2.15 (1.29–3.59)

2.09 (1.25–3.50)

≥90

−10

244,827

151

0.13

1 (ref.)

1 (ref.)

1 (ref.)

1 (ref.)

1 (ref.)

10–14.9

82,712

64

0.15

1.18 (0.88–1.57)

1.20 (0.89–1.60)

1.17 (0.87–1.57)

1.16 (0.87–1.55)

1.15 (0.86–1.56)

15–19.9

10,701

6

0.11

0.83 (0.37–1.88)

0.86 (0.38–1.94)

0.81 (0.36–1.82)

0.81 (0.36–1.83)

0.83 (0.37–1.87)

20–

1758

3

0.34

2.59 (0.82–8.11)

2.66 (0.85–8.36)

2.53 (0.81–7.93)

2.52 (0.80–7.90)

2.48 (0.79–7.79)